CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-03 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −1,018 | $20.41 | $21K | 11,596 |
| 2023-06-28 | GILEAD SCIENCES, INC. 10% owner | Purchase | +1,010,000 | $19.26 | $19.5M | 14,823,029 |
| 2023-06-22 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −12,437 | $19.12 | $238K | 381,566 |
| 2023-06-16 | Tang Carolyn C. General Counsel | Returned to the company 10b5-1 | −2,892 | $19.35 | $56K | 95,902 |
| 2023-06-16 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −12,563 | $19.35 | $243K | 394,003 |
| 2023-06-16 | Jaen Juan C. President | Returned to the company 10b5-1 | −4,820 | $19.35 | $93K | 313,862 |
| 2023-06-16 | ROSEN TERRY J Chief Executive Officer | Returned to the company 10b5-1 | −8,762 | $19.35 | $170K | 3,894,231 |
| 2023-06-15 | Jaen Juan C. President | Gift 10b5-1 | −6,000 | 318,682 | ||
| 2023-06-15 | Lambert Nicole Director | Grant or award | +6,800 | 15,600 | ||
| 2023-06-15 | Lambert Nicole Director | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | ||
| 2023-06-15 | PERLMAN ANDREW J Director | Grant or award | +6,800 | 20,925 | ||
| 2023-06-15 | PERLMAN ANDREW J Director | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | ||
| 2023-06-15 | Lacey David L. Director | Grant or award | +6,800 | 49,252 | ||
| 2023-06-15 | Lacey David L. Director | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | ||
| 2023-06-15 | Ribas Antoni Director | Grant or award | +6,800 | 21,950 | ||
| 2023-06-15 | Ribas Antoni Director | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | ||
| 2023-06-15 | Machado Patrick Director | Grant or award | +6,800 | 16,900 | ||
| 2023-06-15 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | ||
| 2023-06-15 | KANEKO YASUNORI Director | Grant or award | +6,800 | 6,800 | ||
| 2023-06-15 | KANEKO YASUNORI Director | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 |
Page 11 of 20 · 381 trades